Ani Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANI PHARMS, and what generic alternatives to ANI PHARMS drugs are available?
ANI PHARMS has two hundred and forty-two approved drugs.
There are two US patents protecting ANI PHARMS drugs. There is one tentative approval on ANI PHARMS drugs.
There are twenty-nine patent family members on ANI PHARMS drugs in twenty countries and one hundred and seventy supplementary protection certificates in sixteen countries.
Summary for Ani Pharms
| International Patents: | 29 |
| US Patents: | 2 |
| Tradenames: | 153 |
| Ingredients: | 146 |
| NDAs: | 242 |
Drugs and US Patents for Ani Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 205401-006 | Jan 22, 2019 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Ani Pharms | FLECAINIDE ACETATE | flecainide acetate | TABLET;ORAL | 075882-001 | Oct 28, 2002 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Ani Pharms | LUVOX | fluvoxamine maleate | TABLET;ORAL | 021519-001 | Dec 20, 2007 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Ani Pharms | ACETOHEXAMIDE | acetohexamide | TABLET;ORAL | 070870-001 | Feb 9, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Ani Pharms | EXTENDED PHENYTOIN SODIUM | phenytoin sodium | CAPSULE;ORAL | 040435-001 | Jun 20, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Ani Pharms | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-003 | Jun 4, 1998 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Ani Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ani Pharms | VEREGEN | sinecatechins | OINTMENT;TOPICAL | 021902-001 | Oct 31, 2006 | 5,795,911 | ⤷ Try a Trial |
| Ani Pharms | BRETHINE | terbutaline sulfate | TABLET;ORAL | 017849-001 | Approved Prior to Jan 1, 1982 | 3,937,838 | ⤷ Try a Trial |
| Ani Pharms | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-001 | Jun 4, 1998 | 5,534,534*PED | ⤷ Try a Trial |
| Ani Pharms | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-003 | Jun 4, 1998 | 5,703,110 | ⤷ Try a Trial |
| Ani Pharms | LITHOBID | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 018027-001 | Approved Prior to Jan 1, 1982 | 4,264,573 | ⤷ Try a Trial |
| Ani Pharms | ATACAND HCT | candesartan cilexetil; hydrochlorothiazide | TABLET;ORAL | 021093-003 | May 16, 2008 | 7,538,133*PED | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ANI PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 4 mg, 8 mg, 16 mg and 32 mg | ➤ Subscribe | 2006-12-22 |
| ➤ Subscribe | Tablets | 32 mg/25 mg | ➤ Subscribe | 2009-03-06 |
| ➤ Subscribe | Tablets | 16 mg/12.5 mg and 32 mg/12.5 mg | ➤ Subscribe | 2008-06-25 |
International Patents for Ani Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2466720 | ⤷ Try a Trial |
| South Korea | 20050044344 | ⤷ Try a Trial |
| Portugal | 1448186 | ⤷ Try a Trial |
| Germany | 122009000073 | ⤷ Try a Trial |
| China | 1589141 | ⤷ Try a Trial |
| European Patent Office | 2055300 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ani Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0145340 | 99C0005 | Belgium | ⤷ Try a Trial | PRODUCT NAME: FOSPHENYTOIN DISODIUM; NAT. REGISTRATION NO/DATE: NL 23 613 19980806; FIRST REGISTRATION: GB - PL 000 19/0157 19980204 |
| 0443983 | C00443983/03 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: VALSARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE; REGISTRATION NUMBER/DATE: SWISSMEDIC 59407 16.09.2009 |
| 2203431 | 1590018-6 | Sweden | ⤷ Try a Trial | PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119 |
| 0257344 | SPC/GB98/043 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: DIPYRIDAMOLE, OPTIONALLY IN THE FORM OF A PHYSIOLOGICALLY ACCEPTABLE SALT, AND O-ACETYLSALICYLIC ACID, OPTIONALLY IN THE FORM OF A PHYSIOLOGICALLY SALT, I.E. ASASANTIN RETARD; REGISTERED: FR NL 22160 19970709; UK 00015/0224 19980512 |
| 0502314 | SPC/GB02/037 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: TELMISARTAN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/02/213/001 20020419; UK EU/1/02/213/002 20020419; UK EU/1/02/213/003 20020419; UK EU/1/02/214/004 20020419; UK EU/1/02/213/005 20020419; UK EU/1/02/213/006 20020419; UK EU/1/02/213/007 20020419; UK EU/1/02/213/008 20020419; UK EU/1/02/213/009 20020419; UK EU/1/02/213/010 20020419 |
| 0306228 | 38/2000 | Austria | ⤷ Try a Trial | PRODUCT NAME: ROSIGLITAZONE; NAT. REGISTRATION NO/DATE: EU/1/00/137/001 - EU/1/00/137/012 20000711; FIRST REGISTRATION: LI 55176 19990929 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
